Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.Jonathan L. Finlay, Roger J. Packer, Stewart Goldman et al.|Journal of Clinical Oncology|1996Cited by 203
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.Ira J. Dunkel, Jonathan L. Finlay, James M. Boyett et al.|Journal of Clinical Oncology|1998Cited by 188
Health-Related Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Sickle Cell DiseaseMonica Bhatia, Stephen Sands, Eduvigis Cruz-Arrieta et al.|Transplantation and Cellular Therapy|2015Cited by 84
Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphomaPrakash Satwani, Mitchell S. Cairo, Zhezhen Jin et al.|Leukemia|2014Cited by 53
A novel trial of topotecan, ifosfamide, and carboplatin (TIC) in children with recurrent solid tumorsKavita Radhakrishnan, Mitchell S. Cairo, Alice Lee et al.|Pediatric Blood & Cancer|2014Cited by 2